Sodium Storage in Singaporeans
NCT04319068 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2024-08-02
Summary
The overarching hypothesis of this study is that the kidney and the skin form an integrative network for water conservation, where Na+ storage is utilized to prevent body water loss, even at the expense of increased cardiovascular risk. The aim of this project is to characterise skin and muscle Na+ storage in a cohort designed to prospectively measure cardiovascular outcomes in Singaporeans, in order to determine whether humans with increased tissue Na+ storage have increased cardiovascular risk. To gain a better understanding of the mechanisms behind Na+ storage, the investigators will also test the hypothesis that participants with mutations of the skin protein filaggrin, who have increased water loss through the skin, will have increased skin Na+ storage and higher blood pressure levels.
Conditions
- Healthy
- Hypertension
Sponsors & Collaborators
-
National Heart Centre Singapore
collaborator OTHER -
Jens Titze
lead OTHER
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-07-02
- Primary Completion
- 2025-12-31
- Completion
- 2035-12-31
Countries
- Singapore
Study Locations
More Related Trials
-
Sodium Diet Effect on Aldosterone and Urinary RNA (SALTY)
NCT04168073 ·Status: COMPLETED ·Phase: NA
-
Tissue Sodium in Pre-hypertensive Patients
NCT02236520 ·Status: COMPLETED ·Phase: PHASE2
-
International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430
NCT01056848 ·Status: COMPLETED
-
Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function.
NCT00405548 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism
NCT03174847 ·Status: COMPLETED
-
Sodium-Endothelial Function-CKD Study
NCT00141622 ·Status: COMPLETED ·Phase: NA
-
Validation of New Diagnostic Indices to Simplify Hyponatremia Therapy Assessment in Patients on Thiazide Diuretics
NCT06381934 ·Status: RECRUITING ·Phase: NA
-
Mineralocorticoid Receptor (MR) Antagonist (Eplerenone) vs Amlodipine and STRIATIN
NCT03683069 ·Status: COMPLETED ·Phase: PHASE4
-
Cardiovascular Evaluation of Adult PHA 1 Patients
NCT00646828 ·Status: COMPLETED
-
Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure
NCT02352285 ·Status: TERMINATED ·Phase: PHASE4
-
Prospective Phenotyping of Autonomous Aldosterone Secretion
NCT03484130 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of the Efficacy of rhBNP in Patients With Diuretic Resistance After Cardiac Surgery
NCT07086287 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Are we Loading Our Patients With Sodium During Hemodialysis Treatments?
NCT01454193 ·Status: COMPLETED
-
The Effect of SAAE on Vascular Endothelial Function in PA Patients
NCT05561361 ·Status: RECRUITING
-
Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension
NCT01468571 ·Status: UNKNOWN ·Phase: PHASE4
-
Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
NCT00865124 ·Status: COMPLETED ·Phase: NA
-
Association of Diuretics With Change in Extracellular Volume, Natriuretic Peptides, Symptoms, and Cardiovascular Outcomes in CKD
NCT04192110 ·Status: WITHDRAWN ·Phase: PHASE4
-
THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation
NCT00578695 ·Status: COMPLETED ·Phase: PHASE3
-
Diagnosing Variable Primary Aldosteronism.
NCT05765786 ·Status: RECRUITING
-
Acute Salt Handling in Orthostatic Intolerance
NCT00581633 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Electronic Alert to Improve Testing For Primary Aldosteronism in Patients With Hypertension
NCT05925569 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
International, Multicenter, Open-Label and Randomized Withdrawal Study of Oral Lixivaptan in Heart Failure Patients With Chronic Hyponatremia
NCT00876876 ·Status: WITHDRAWN ·Phase: PHASE3
-
Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart Failure
NCT00170183 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Low Salt and Ckd Progression
NCT05716386 ·Status: COMPLETED ·Phase: NA
-
Studies on Aldosterone and Vascular Function
NCT00700479 ·Status: COMPLETED ·Phase: PHASE1